ReWalk Robotics (NASDAQ:RWLK) Receives New Coverage from Analysts at StockNews.com

Posted by on Jun 23rd, 2023

Stock analysts at StockNews.com assumed coverage on shares of ReWalk Robotics (NASDAQ:RWLK – Get Rating) in a note issued to investors on Friday. The brokerage set a “sell” rating on the medical device company’s stock.

Separately, HC Wainwright restated a “buy” rating and issued a $3.00 price objective on shares of ReWalk Robotics in a report on Friday, February 24th.

ReWalk Robotics Price Performance

Shares of NASDAQ:RWLK opened at $0.59 on Friday. The business’s 50 day moving average price is $0.61 and its 200-day moving average price is $0.72. The firm has a market capitalization of $35.18 million, a price-to-earnings ratio of -1.85 and a beta of 2.47. ReWalk Robotics has a 1 year low of $0.56 and a 1 year high of $1.14.

ReWalk Robotics (NASDAQ:RWLK – Get Rating) last announced its quarterly earnings data on Thursday, May 11th. The medical device company reported ($0.07) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.01. The company had revenue of $1.23 million for the quarter, compared to analyst estimates of $2.00 million. ReWalk Robotics had a negative return on equity of 27.12% and a negative net margin of 333.16%. On average, sell-side analysts expect that ReWalk Robotics will post -0.29 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Renaissance Technologies LLC raised its holdings in shares of ReWalk Robotics by 23.0% during the 1st quarter. Renaissance Technologies LLC now owns 180,500 shares of the medical device company’s stock worth $130,000 after acquiring an additional 33,700 shares during the period. Millennium Management LLC raised its holdings in shares of ReWalk Robotics by 42.9% during the 4th quarter. Millennium Management LLC now owns 139,009 shares of the medical device company’s stock worth $106,000 after acquiring an additional 41,753 shares during the period. Finally, Virtu Financial LLC raised its holdings in shares of ReWalk Robotics by 249.6% during the 4th quarter. Virtu Financial LLC now owns 47,638 shares of the medical device company’s stock worth $36,000 after acquiring an additional 34,013 shares during the period. Hedge funds and other institutional investors own 19.90% of the company’s stock.

About ReWalk Robotics

(Get Rating)

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic.

Read More

Receive News & Ratings for ReWalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.